Unveiling the cholesterol-hemangioma axis: a path to new treatments
- PMID: 40166936
- PMCID: PMC11957685
- DOI: 10.1172/JCI193039
Unveiling the cholesterol-hemangioma axis: a path to new treatments
Conflict of interest statement
Similar articles
-
Apolipoprotein A-I Binding Protein Inhibits the Formation of Infantile Hemangioma through Cholesterol-Regulated Hypoxia-Inducible Factor 1α Activation.J Invest Dermatol. 2024 Mar;144(3):645-658.e7. doi: 10.1016/j.jid.2023.07.030. Epub 2023 Oct 11. J Invest Dermatol. 2024. PMID: 37832842
-
Management of a Large Congenital Hemangioma Obstructing Visual Axis: A Case Report and Review of Literature.Ophthalmic Plast Reconstr Surg. 2019 Nov/Dec;35(6):e154-e157. doi: 10.1097/IOP.0000000000001490. Ophthalmic Plast Reconstr Surg. 2019. PMID: 31593044 Review.
-
[Racemose hemangioma of the bronchial artery].Nihon Rinsho. 2009 May;67(5):1038-41. Nihon Rinsho. 2009. PMID: 19432130 Review. Japanese.
-
New dosimetry for childhood skin hemangioma treatments with (226)Ra needles or tubes.Radiother Oncol. 2015 Jul;116(1):139-42. doi: 10.1016/j.radonc.2015.06.014. Epub 2015 Jun 21. Radiother Oncol. 2015. PMID: 26104976
-
LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis.Hum Genomics. 2021 Aug 6;15(1):50. doi: 10.1186/s40246-021-00349-w. Hum Genomics. 2021. PMID: 34362467 Free PMC article.
References
LinkOut - more resources
Full Text Sources